stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Inhibikase Therapeutics IncIKT
$1.321.54%0.02

Inhibikase Therapeutics Inc (IKT)

Inhibikase Therapeutics Inc (IKT) 재무 분석

*모든 숫자는 백만 단위입니다.
기간 종료일2026-09-302026-06-302026-03-312025-12-312025-09-30
기간3개월3개월3개월3개월3개월
5.59%7.23
7.667.386.775.61
Selling, General, and Administrative
5.59%7.23
7.667.386.775.61
Research and Development
11.99%15.00
13.3910.846.367.65
Costs And Expenses
5.60%22.23
21.0517.8413.7812.77
Operating Income/Loss
5.60%-22.23
-21.05-17.84-13.78-12.77
Net Interest Income/Expense
20.69%1.76
1.461.461.040.84
4.47%-20.47
-19.59-16.38-12.73-11.93
Attributable To Parent
4.47%-20.47
-19.59-16.38-12.73-11.93
Basic Average Shares
12.81%196.94
174.57172.31-90.05
Diluted Average Shares
12.81%196.94
174.57172.31-90.05
Basic Earnings Per Share
9.09%-0.10
-0.11-0.10--0.13
Diluted Earnings Per Share
9.09%-0.10
-0.11-0.10--0.13

IKT와(과) 유사한 종목